The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 09, 2024

Filed:

Aug. 19, 2020
Applicant:

Newish Technology (Beijing) Co., Ltd., Beijing, CN;

Inventors:

Zhongjie Sun, Beijing, CN;

Hailong Qi, Beijing, CN;

Ligong Chen, Beijing, CN;

Huangfan Xie, Beijing, CN;

Defang Liu, Beijing, CN;

Xiao E. Yan, Beijing, CN;

Weiwei Li, Beijing, CN;

Xiaofang Wang, Beijing, CN;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); A61P 35/00 (2006.01); A61K 31/351 (2006.01);
U.S. Cl.
CPC ...
A61K 38/005 (2013.01); A61K 38/179 (2013.01); A61K 38/1866 (2013.01); A61P 35/00 (2018.01); A61K 31/351 (2013.01);
Abstract

The present invention relates to the field of medical technology, in particular to a composition for treating cancer and use and medicament thereof. The composition comprises an SGLT1 inhibitor and a VEGFR2 inhibitor. The present invention finds that SGLT1 interacts with VEGFR2 to promote the development and progression of tumors; the present invention also finds that a composition of a VEGFR2 targeting inhibitor and an SGLT1 inhibitor has a synergistic anti-tumor effect, and the composition of the VEGFR2 targeting inhibitor and the SGLT1 targeting inhibitor can be used in cancer treatment.


Find Patent Forward Citations

Loading…